It’s more to act as a reward for developing things normal incentives wouldn’t otherwise fund. Ie companies love to develop long term treatments but actual, “one

It’s more to act as a reward for developing things normal incentives wouldn’t otherwise fund. Ie companies love to develop long term treatments but actual, “one treatment” cures wouldn’t be developed as they’re not long term revenue streams. Other meds go undeveloped for similar reasons. If the government will reward development of such treatments then there’s the possibility to be massively rewarded for developing otherwise “unrewarded” treatments.